Exponent, Inc. (EXPO)
| Market Cap | 4.00B +7.4% |
| Revenue (ttm) | 583.12M +9.8% |
| Net Income | 114.67M +9.4% |
| EPS | 2.32 +14.1% |
| Shares Out | 47.55M |
| PE Ratio | 36.26 |
| Forward PE | 26.83 |
| Dividend | $1.24 (1.48%) |
| Ex-Dividend Date | Dec 4, 2026 |
| Volume | 365,028 |
| Open | 84.35 |
| Previous Close | 85.83 |
| Day's Range | 82.28 - 85.22 |
| 52-Week Range | 51.91 - 90.51 |
| Beta | 0.68 |
| Analysts | Buy |
| Price Target | 90.67 (+7.92%) |
| Earnings Date | Oct 29, 2026 |
About EXPO
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and ... [Read more]
Financial Performance
In fiscal year 2025, Exponent's revenue was $536.76 million, an increase of 3.52% compared to the previous year's $518.49 million. Earnings were $106.01 million, a decrease of -2.75%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for EXPO stock is "Buy." The 12-month stock price target is $90.67, which is an increase of 7.92% from the latest price.
News
Exponent price target raised to $100 from $90 at JPMorgan
JPMorgan raised the firm’s price target on Exponent (EXPO) to $100 from $90 and keeps an Overweight rating on the shares.
Exponent price target raised to $82 from $72 at UBS
UBS raised the firm’s price target on Exponent (EXPO) to $82 from $72 and keeps a Neutral rating on the shares.
Exponent Earnings Call Transcript: Q3 2026
Q3 net revenue rose 12% and EBITDA margin expanded to 29.4%, supported by broad demand and higher utilization. FY26 net revenue growth guidance increased to 10%-11%, with EBITDA margin guidance of 28%-28.3%.
Exponent Earnings release: Q3 2026
Exponent released its Q3 2026 earnings on October 29, 2026, summarizing the period's financial results.
Exponent Quarterly report: Q3 2026
Exponent has published its Q3 2026 quarterly earnings report on October 29, 2026.
Exponent reports Q3 EPS 64c, consensus 62c
Reports Q3 revenue $173.73M, consensus $153.43M. “Exponent (EXPO) delivered another strong quarter, with double-digit growth in revenues and earnings, reflecting continued demand for our specialized, ...
Exponent sees Q4 revenue before reimbursements up 8%-10%
Sees Q4 EBITDA 26.3%-26.8% of revenue. “Our ability to scale our operating model in response to market demand resulted in 77% utilization and expanded profitability during the third quarter of…
Exponent raises FY26 revenue view to up 10%-11% from up 9%-10%
Raises FY26 EBITDA view to 28%-28.3% of revenues from 27.8%-28.1% of revenues. “Rapid innovation continues to reshape industries as companies race to make physical products more intelligent, while exp...
Exponent Reports Third Quarter 2026 Financial Results
MENLO PARK, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2026 ended October 2, 2026.
Exponent Declares Regular Quarterly Dividend for Q4 2026
MENLO PARK, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stoc...
Exponent to Announce Third Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on October 29, 2026
MENLO PARK, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report third quarter of fiscal year 2026 financial results for the period ended Octobe...
Exponent Hosts Investor Day
Event showcased the multidisciplinary science and engineering behind its growth Event showcased the multidisciplinary science and engineering behind its growth
Exponent price target raised to $90 from $80 at JPMorgan
JPMorgan raised the firm’s price target on Exponent (EXPO) to $90 from $80 and keeps an Overweight rating on the shares.
Exponent price target lowered to $72 from $75 at UBS
UBS lowered the firm’s price target on Exponent (EXPO) to $72 from $75 and keeps a Neutral rating on the shares. Exponent posted a “good” quarter with an improved outlook…
Exponent increases share repurchase program by $50M
Exponent’s (EXPO) board of directors increased the company’s authority to repurchase shares of its common stock by $50M. “Our quarterly dividend and increased share repurchase authorization reflects t...
Exponent Earnings Call Transcript: Q2 2026
Q2 2026 saw double-digit revenue and earnings growth, driven by strong demand for both proactive and reactive expertise, especially in AI-enabled products and infrastructure. Guidance for 2026 was raised, with continued investment in talent and shareholder returns.
Exponent Earnings release: Q2 2026
Exponent released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Exponent Slides: Q2 2026
Exponent has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Exponent Quarterly report: Q2 2026
Exponent has published its Q2 2026 quarterly earnings report on July 30, 2026.
Exponent sees Q3 revenue up 8%-10%
Sees Q3 adjusted EBITDA 28%-28.5% of revenue before reimbursements. “These results reflect the powerful long-term trends driving our business, including rapid technological innovation, increasing comp...
Exponent raises FY26 revenue view to up 9%-10% from up high-single digits
Raises FY26 adjusted EBITDA view to 27.8%-28.1% from 27.6%-28.1% of revenue before reimbursements. “Our second quarter results demonstrate continued disciplined execution across the business, with str...
Exponent reports Q2 EPS 60c, consensus 60c
Reports Q2 revenue before reimbursements $148.86M, consensus $147.49M. “Exponent (EXPO) delivered another strong quarter, with double-digit growth in revenues and earnings reflecting continued demand ...
Exponent Declares Regular Quarterly Dividend for Q3 2026 and Increases Stock Repurchase Authorization by $50 Million
MENLO PARK, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stoc...
Exponent Reports Second Quarter 2026 Financial Results
MENLO PARK, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2026 ended July 3, 2026.
Exponent to Announce Second Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on July 30, 2026
MENLO PARK, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2026 financial results for the period ended July ...